International Medical Prosthetics Research Associates, Inc., D/B/A Impra, Inc. v. Gore Enterprise Holdings, Inc., and W.L. Gore and Associates, Inc.

787 F.2d 572, 229 U.S.P.Q. (BNA) 278, 1986 U.S. App. LEXIS 20038
CourtCourt of Appeals for the Federal Circuit
DecidedApril 1, 1986
DocketAppeal 85-2744
StatusPublished
Cited by41 cases

This text of 787 F.2d 572 (International Medical Prosthetics Research Associates, Inc., D/B/A Impra, Inc. v. Gore Enterprise Holdings, Inc., and W.L. Gore and Associates, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
International Medical Prosthetics Research Associates, Inc., D/B/A Impra, Inc. v. Gore Enterprise Holdings, Inc., and W.L. Gore and Associates, Inc., 787 F.2d 572, 229 U.S.P.Q. (BNA) 278, 1986 U.S. App. LEXIS 20038 (Fed. Cir. 1986).

Opinion

MARKEY, Chief Judge.

International Medical Prosthetics Research Associates, Inc. (IMPRA) appeals from a judgment of the United States District Court for the District of Arizona dismissing IMPRA’s complaint as not within its subject matter jurisdiction. The judgment was entered in response to a motion filed under Rule 12(b) by Gore Enterprise Holdings, Inc. and W.L. Gore Associates, Inc. (Gore), challenging IMPRA’s complaint for declaratory judgment of invalidity of Gore-owned Patent No. 3,953,566 (’566 patent) for failure of IMPRA to establish existence of an actual controversy. We vacate and remand.

Background

This appeal represents one of many sideline skirmishes between the parties to an eleven-year corporate confrontation over the use of a process for producing porous articles of polytetrafluoroethylene (PTFE) and the marketing of products produced of PTFE. 1 In April 1984, Gore sued IMPRA for infringement of Gore’s U.S. Patent No. 4,187,390 (’390 patent) directed to a product formed of PTFE.

In February 1985, IMPRA filed a complaint seeking a declaratory judgment that Gore’s ’566 patent was invalid. The ’566 patent is directed to a process for producing PTFE. In March 1985, the court consolidated the two actions. Between April 1984 and September 1985, the parties’ pretrial activities produced 782 entries in the trial court’s docket.

Asserting that it has not charged IMPRA with infringement of its ’566 patent, Gore moved under Rule 12(b) for dismissal of IMPRA’s declaratory judgment complaint, asserting inter alia the absence of an actual controversy and thus a lack of subject matter jurisdiction. 2 The district court granted the motion and IMPRA appealed.

Issue

Whether the district court erred in granting the motion for dismissal.

*574 (1) The Case

The present appeal presents a scenario that, it can be fervently hoped, will occur less frequently in future. Though the district court entered no findings or conclusions on a large number of allegations and assertions, the parties have elected to burden this court with arguments thereon, in a false and improper expectation that we will find the facts necessary to support their respective positions. Each charges the other with impropriety respecting the record and the appendices.

The case is unusual on its facts. The district court had cited to and apparently relied on Jervis B. Webb Co. v. Southern Systems, Inc., 742 F.2d 1388, 222 USPQ 943 (Fed.Cir.1984). Like the more “normal” case, Jervis B. Webb Co. involved one action, a patentee’s suit for infringement of only six claims, and the defendant’s counterclaim for a declaration that all twelve claims of the patent were invalid. In the present case two patents, the ‘390 patent claiming a product and the ‘566 patent claiming a process for making the product, issued as a result of a single patent application. The patentee, Gore, sued IMPRA on the former but not on the latter, and IMPRA says it seeks to settle the entire controversy by obtaining a declaration that the ‘566 patent is invalid, fearing a Pyrric victory if it wins the suit on the ‘390 patent but must then face a lawsuit on the ‘566 patent. 3

(2) The Grant of the Motion

On July 8, 1985, in granting Gore’s motion to dismiss, the district court said:

Well, I’m going to grant the motion to dismiss on the basis of lack of subject matter jurisdiction. I think the other bases are good, really, in proper [sic] service, venue, indispensable party, but those can really be cured by the the [sic] counterclaim, but the basis is the lack of subject matter jurisdiction.

On July 9, 1985, following a hearing on a different motion in the consolidated case, counsel engaged in this colloquy with the court about the July 8 dismissal:

Mr. North: [IMPRA’s counsel] So the holding was that we didn’t allege that we made an infringing product, and my argument to you was that all we were required to do was say we made a product that is accused. And you interpreted the Webb case to mean we must actually say we’re infringing?
The Court: Yes. That’s my interpretation.
Mr. North: Well, Your Honor — we must admit that we’re infringing in order to seek declaratory relief under [the] patent laws?
The Court: That’s my understanding of it.
Mr. Pfeffer: [Gore’s counsel] Well, Your Honor, I understand it there was a particular requirement of the claim, and their assertions keep on being that they’re not following that particular requirement of ten percent per second. That’s their position.
Mr. North: That’s correct.
Mr. Pfeffer [erroneously designated as Mr. North in the hearing transcript]: And according to the Webb case if somebody takes a position that they’re not following a material portion of a claim then they’re not entitled to declaratory judgment.
The Court: That’s the way I ruled. 4

The judgment granting the motion merely says, as is appropriate in a judgment, “that plaintiff take nothing and the action is dismissed.” The district court entered no findings or conclusions and filed no memorandum or opinion. We have before us, therefore, as the sole basis for the *575 judgment, the statements of the district court quoted above. 5

(3) Admission of Infringement

There is, of course, no “rule” that parties seeking a declaratory judgment of patent invalidity must show an actual controversy by admitting “infringement.” Such an admission can have legal consequences beyond those that might result from an admission that one is making a product or practicing a process that is accused or that might at trial be found an infringement. Declaratory judgment plaintiffs who have been accused of infringement or threatened with suit are at full liberty to deny infringement and often do. They are at liberty, also, to admit infringement while asserting that the patent is invalid and that no liability for the infringement can therefore exist. Indeed, when the latter is the truth, admission of infringement is to be encouraged as a means of limiting the issues to be tried. Thus, whether infringement is admitted is not alone determinative. It is difficult to conceive of a justiciable controversy when neither party says there is any possibility of infringement, yet no court has held that a declaratory judgment plaintiff must always admit infringement.

What counts is whether an actual controversy exists.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Raymond v. Conine
D. Nevada, 2024
Pfizer Inc. v. Apotex Inc.
726 F. Supp. 2d 921 (N.D. Illinois, 2010)
Streck, Inc. v. Research & Diagnostic Systems, Inc.
658 F. Supp. 2d 988 (D. Nebraska, 2009)
Janssen Pharmaceutica, NV v. Apotex, Inc.
540 F.3d 1353 (Federal Circuit, 2008)
FieldTurf USA, Inc. v. Sports Construction Group, LLC
507 F. Supp. 2d 801 (N.D. Ohio, 2007)
Benitec Australia, Ltd. v. Nucleonics, Inc.
495 F.3d 1340 (Federal Circuit, 2007)
True Center Gate Leasing, Inc. v. Sonoran Gate, L.L.C.
402 F. Supp. 2d 1093 (D. Arizona, 2005)
Glaxo Group Ltd. v. DR. REDDY'S LABORATORIES, LTD.
325 F. Supp. 2d 502 (D. New Jersey, 2004)
Eva v. Midwest National Mortgage Banc, Inc.
143 F. Supp. 2d 862 (N.D. Ohio, 2001)
SNA, Inc. v. Array
51 F. Supp. 2d 554 (E.D. Pennsylvania, 1999)
SL Waber, Inc. v. American Power Conversion Corp.
135 F. Supp. 2d 521 (D. New Jersey, 1999)
Evans Medical Ltd. v. American Cyanamid Co.
980 F. Supp. 132 (S.D. New York, 1997)
CAE Screenplates, Inc. v. Beloit Corp.
957 F. Supp. 784 (E.D. Virginia, 1997)
Level 1 Technologies, Inc. v. C.R. Bard, Inc.
839 F. Supp. 90 (D. Massachusetts, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
787 F.2d 572, 229 U.S.P.Q. (BNA) 278, 1986 U.S. App. LEXIS 20038, Counsel Stack Legal Research, https://law.counselstack.com/opinion/international-medical-prosthetics-research-associates-inc-dba-impra-cafc-1986.